MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0195680
Danlion Pharmaceuticals Private Limited
Danlion Pharmaceuticals Private Limited - service in Fursungi, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.17 Cr
▲ 36% YoY
Net profit · FY 2025
₹13.08 Lakh
Net margin 4.1%
EBITDA · FY 2025
₹31.19 Lakh
EBITDA margin 9.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹45 Lakh
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
About Danlion Pharmaceuticals Private Limited
Data last updated:
Danlion Pharmaceuticals Private Limited is a private limited company based in Fursungi, Maharashtra, India. It operates in the service-based operations segment of the services sector. It was incorporated on 05 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U93090PN2017PTC171285. Its GSTIN is 27AAGCD2499B1ZO (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satveek Hanumant Giramkar and Premchand Ramchandra Bhusanar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Godown No 2 Ground Floor Milkat No 17660 Se.No 166/1/1 Fursungi, Maharashtra, India – 412308.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.17 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹13.08 Lakh (net margin 4.1%) and EBITDA of ₹31.19 Lakh (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 66% over three years and 47% over five years.
As per MCA filings, the company has open charges of ₹45 Lakh on record.
Danlion Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0195680). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U93090PN2017PTC171285
Registration Number 171285
Incorporation Date 05 July 2017
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0195680
Key People
Satveek Hanumant Giramkar Director Premchand Ramchandra Bhusanar Director Jitendra Kalpnath Singh Director Recognitions & Rankings of Danlion Pharmaceuticals
Contact details
Danlion Pharmaceuticals Private Limited's registered office is in Fursungi, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressGodown No 2 Ground Floor Milkat No 17660 Se.No 166/1/1 Fursungi, Maharashtra, India – 412308
- IndustryService, Other Services
To see the full contact details of Danlion Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Danlion Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Danlion Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Danlion Pharmaceuticals Private Limited, buy the company report.
Financials of Danlion Pharmaceuticals Private Limited
FY 2025 filings availableDanlion Pharmaceuticals Private Limited reported revenue of ₹3.17 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹3.17 Cr ▲ 36%
Net profit · FY 2025
₹13.08 Lakh margin 4.1%
EBITDA · FY 2025
₹31.19 Lakh margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 66%
5 years · compounded
▲ 47%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 61%
5 years · compounded
▲ 68%
Revenue has grown at a compounded annual rate (CAGR) of 47% over five years, including 36% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Danlion Pharmaceuticals Private Limited, buy the company report.
Board of directors of Danlion Pharmaceuticals Private Limited
Danlion Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satveek Hanumant Giramkar | Director | 05 Jul 2017 | 9 Years 3 Months | Current |
| Premchand Ramchandra Bhusanar Also directs: Backlinks Biotech India Private Limited | Director | 05 Jul 2017 | 9 Years 3 Months | Current |
| Jitendra Kalpnath Singh | Director | 05 Jul 2017 | 9 Years 3 Months | Current |
Charges & borrowings
Open charges
₹45 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2024 | 101027294 | Others | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Danlion Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Danlion Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Danlion Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD2499B1ZO | Maharashtra | Active | 29 Aug 2017 |
To see the full GST registrations and return filing status of Danlion Pharmaceuticals Private Limited, buy the company report.
Recent activity
Danlion Pharmaceuticals Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Ketaki Vishal Satte ceased to be Additional Director on 30 Sep 2019.
AGM
Danlion Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Danlion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Others amounted to Rs. 45.00 Lakh with Charge ID 101027294 was registered on 27 Dec 2024.
Ceased
Ketaki Vishal Satte ceased to be Additional Director.
Appointed
Jitendra Kalpnath Singh was appointed as Director.
Appointed
Premchand Ramchandra Bhusanar was appointed as Director.
Appointed
Satveek Hanumant Giramkar was appointed as Director.
Incorporation
05 Jul 2017
Danlion Pharmaceuticals Private Limited was registered on 05 Jul 2017 with Roc Pune & aged 9 years 3 months as per MCA records.
Frequently asked questions
Danlion Pharmaceuticals is an active private limited company based in Fursungi, Maharashtra, India. The company works in other services, within the service industry. It was incorporated on 05 July 2017 (9+ years old) and is registered under CIN U93090PN2017PTC171285.
Danlion Pharmaceuticals has 3 current directors:
- Satveek Hanumant Giramkar - Director
- Premchand Ramchandra Bhusanar - Director
- Jitendra Kalpnath Singh - Director
The latest financial statements of Danlion Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Danlion Pharmaceuticals is 27AAGCD2499B1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Danlion Pharmaceuticals is U93090PN2017PTC171285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Danlion Pharmaceuticals was incorporated on 05 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Ketaki Vishal Satte ceased to be Additional Director on 30 Sep 2019. Jitendra Kalpnath Singh was appointed as Director on 05 Jul 2017. Premchand Ramchandra Bhusanar was appointed as Director on 05 Jul 2017. Danlion Pharmaceuticals has 4 board changes on record in total.
Yes, Danlion Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0195680).
The registered office of Danlion Pharmaceuticals is at Godown No 2 Ground Floor Milkat No 17660 Se.No 16611 Fursungi, Maharashtra, India – 412308.
Danlion Pharmaceuticals operates in the service industry, in the other services segment.